Cyalume Technologies (CYLU) 10-Q 14 Nov 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 12, 2014
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Entity Registrant Name	'Cyalume Technologies Holdings, Inc.	'
Entity Central Index Key	'0001335293	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Trading Symbol	'CYLU	'
Entity Common Stock, Shares Outstanding	'	21,400,244

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash	$848	$865
Accounts receivable, net of allowance for doubtful accounts of $49 and $44, respectively	3,888	3,788
Inventories, net	9,121	10,782
Income taxes refundable	0	163
Deferred income taxes	3,847	3,847
Prepaid expenses and other current assets	520	463
Total current assets	18,224	19,908
Property, plant and equipment, net	7,123	8,001
Goodwill	7,992	7,992
Other intangible assets, net	7,365	17,948
Other noncurrent assets	24	465
Total assets	40,728	54,314
Current liabilities:	'	'
Line of credit	1,750	1,600
Current portion of notes payable	1,893	1,925
Accounts payable	4,437	6,182
Accrued expenses	2,041	2,059
Deferred revenue	91	80
Income taxes payable	186	97
Current portion of capital lease obligation	11	15
Warrants liability	33	6,373
Deferred rent	78	0
Contingent legal obligation	0	3,986
Other current liabilities	0	242
Total current liabilities	10,520	22,559
Notes payable, net of current portion	14,251	14,969
Note payable due to related parties	2,100	2,100
Deferred income taxes	3,847	3,847
Asset retirement obligation	201	194
Capital lease obligation, net of current portion	0	7
Contingent legal obligation, net of current portion	2,781	0
Other noncurrent liabilities, net of current portion	72	79
Total liabilities	33,772	43,755
Commitments and contingencies (Note 11)	'	'
Stockholders' equity:	'	'
Common stock, $0.001 par value; 100,000,000 shares authorized; 21,400,244 and 20,738,260 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively	21	21
Additional paid-in capital	103,128	102,575
Accumulated deficit	-103,549	-95,874
Accumulated other comprehensive loss	-516	-218
Total stockholders' equity	485	6,504
Total liabilities and stockholders' equity	40,728	54,314
Series A Convertible Preferred Stock [Member]	'	'
Temporary Equity	'	'
Temporary Equity	4,430	4,055
Series B Convertible Preferred Stock [Member]	'	'
Stockholders' equity:	'	'
Preferred Stock	1,401	0
Series C Preferred Stock [Member]	'	'
Temporary Equity	'	'
Temporary Equity	$2,041	$0

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Accounts receivable, allowance for doubtful accounts	$49	$44
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	21,400,244	20,738,260
Common stock, shares outstanding	21,400,244	20,738,260
Series A Convertible Preferred Stock [Member]	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	123,077	123,077
Preferred stock, shares outstanding	123,077	123,077
Series B Convertible Preferred Stock [Member]	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000
Series C Convertible Preferred Stock [Member]	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	1,000	1,000
Preferred stock, shares outstanding	1,000	1,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Comprehensive Loss (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues	$8,387	$7,461	$24,543	$25,006
Cost of revenues	4,515	4,217	14,243	13,453
Gross profit	3,872	3,244	10,300	11,553
Other expenses (income):	'	'	'	'
Sales and marketing	966	1,200	2,831	3,650
General and administrative	1,641	4,411	5,114	9,107
Research and development	432	371	1,186	1,431
Interest expense, net	526	620	1,563	1,790
Interest expense - related party	68	122	291	174
Amortization of intangible assets	564	434	1,557	1,303
Provision for uncollectible receivable - related party	0	3,730	0	3,730
Change in warrant liability fair value	197	0	-4,844	0
Impairment loss on intangible assets	9,100	0	9,100	875
Impairment loss on goodwill	0	0	0	168
Legal settlement	0	2,038	0	2,038
Loss on extinguishment of related party debt	527	0	527	0
Other expenses, net	12	45	363	49
Total other expenses, net	14,033	12,971	17,688	24,315
Loss before income taxes	-10,161	-9,727	-7,388	-12,762
Provision for (benefit from) income taxes	112	-1,923	287	-3,100
Net loss	-10,273	-7,804	-7,675	-9,662
Other comprehensive (loss) income, net of tax:	'	'	'	'
Foreign currency translation adjustments	-246	199	-298	105
Unrealized gain on cash flow hedges, net of taxes of $0, $(14), $0 and $(28) respectively	0	22	0	70
Other comprehensive (loss) income	-246	221	-298	175
Comprehensive loss	-10,519	-7,583	-7,973	-9,487
Net loss	-10,273	-7,804	-7,675	-9,662
Net Income (Loss) Available to Common Stockholders	'	'	'	'
Net loss available to common stockholders	-15,365	-7,804	-13,012	-9,662
Net loss per common share:	'	'	'	'
Basic	($0.72)	($0.38)	($0.61)	($0.47)
Diluted	($0.72)	($0.38)	($0.61)	($0.47)
Weighted average shares used to compute net loss per common share:	'	'	'	'
Basic	21,400,244	20,716,901	21,258,011	20,711,352
Diluted	21,400,244	20,716,901	21,258,011	20,711,352
Series A Convertible Preferred Stock [Member]	'	'	'	'
Net Income (Loss) Available to Common Stockholders	'	'	'	'
Preferred stock dividends	-130	0	-375	0
Series C Preferred Stock [Member]	'	'	'	'
Net Income (Loss) Available to Common Stockholders	'	'	'	'
Preferred stock dividends	-41	0	-41	0
Series A Deemed Dividend [Member]	'	'	'	'
Net Income (Loss) Available to Common Stockholders	'	'	'	'
Preferred stock dividends	-2,422	0	-2,422	0
Series B Deemed Dividend [Member]	'	'	'	'
Net Income (Loss) Available to Common Stockholders	'	'	'	'
Preferred stock dividends	-1,098	0	-1,098	0
Series C Deemed Dividend [Member]	'	'	'	'
Net Income (Loss) Available to Common Stockholders	'	'	'	'
Preferred stock dividends	($1,401)	$0	($1,401)	$0

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Loss (Parenthetical) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Unrealized gain (loss) on cash flow hedges, taxes	$0	($14)	$0	($28)

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Changes in Preferred Stock and Stockholders' Equity (USD $)	Total	Series A And Series C Preferred Stock [Member]	Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
In Thousands, except Share data
Beginning balance at Dec. 31, 2013	$6,504	$4,055	$0	$21	$102,575	($95,874)	($218)
Beginning balance (in shares) at Dec. 31, 2013	'	'	0	20,738,260	'	'	'
Proceeds received from issuance of Series C preferred stock (in shares)	'	'	0	0	'	'	'
Proceeds received from issuance of Series C preferred stock	0	1,000	0	0	0	0	0
Proceeds received from issuance of Series B convertible preferred stock (in shares)	'	'	1,000	0	'	'	'
Proceeds received from issuance of Series B convertible preferred stock	1,000	0	1,000	0	0	0	0
Series A, B and C allocation of fair value	401	-401	401	0	0	0	0
Series A, B and C preferred stock issuance costs	-321	0	0	0	-321	0	0
Dividends accrued on Series A and Series C preferred stock	-416	416	0	0	-416	0	0
Reversal of forfeited restricted awards (in shares)	'	'	0	-3,333	'	'	'
Reversal of forfeited restricted awards	0	0	0	0	0	0	0
Warrants amended in connection with refinancing	-72	0	0	0	-72	0	0
Common stock issuance - payment of contingent consideration liability (in shares)	'	'	0	350,000	'	'	'
Common stock issuance - payment of contingent consideration liability	241	0	0	0	241	0	0
Shares issued to related party	157	0	0	0	157	0	0
Shares issued to related party (in shares)	'	'	0	242,308	'	'	'
Shares issued - warrant exercise (in shares)	'	'	0	73,009	'	'	'
Shares issued - warrant exercise	45	0	0	0	45	0	0
Excess of Amended JFC Note fair value over face value	483	0	0	0	483	0	0
Termination of USVC common and preferred warrants (See Note 7)	1,524	0	0	0	1,524	0	0
Series C deemed dividends (See Note 7)	-1,401	1,401	0	0	-1,401	0	0
Share-based compensation expense (in shares)	'	'	0	0	'	'	'
Share-based compensation expense	313	0	0	0	313	0	0
Net loss	-7,675	0	0	0	0	-7,675	0
Other comprehensive loss	-298	0	0	0	0	0	-298
Ending balance at Sep. 30, 2014	$485	$6,471	$1,401	$21	$103,128	($103,549)	($516)
Ending balance (in shares) at Sep. 30, 2014	'	'	1,000	21,400,244	'	'	'

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Net loss	($7,675)	($9,662)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:	'	'
Depreciation and amortization of property, plant and equipment	1,059	1,030
Amortization	1,736	1,839
Provision for uncollectible receivable - related party	0	3,730
Non-cash interest expense	750	0
Deferred income tax provision	0	-3,261
Share-based compensation expense	313	709
Impairment loss on intangible assets	9,100	875
Impairment loss on goodwill	0	168
Change in fair value of warrant liability	-4,844	0
Legal settlement	0	2,038
Loss on extinguishment of debt - related party	527	0
Other non-cash expenses	54	45
Changes in operating assets and liabilities:	'	'
Accounts receivable	-161	-252
Inventories	1,568	-1,701
Prepaid expenses and other current assets	290	-494
Accounts payable and accrued liabilities	-1,662	2,555
Accrued interest on note payable to related party	188	0
Deferred revenue and deferred rent	89	58
Income taxes payable	261	43
Net cash provided by (used in) operating activities	1,593	-2,280
Cash flows from investing activities:	'	'
Purchases of long-lived assets	-302	-801
Payment of trademark costs	-4	0
Payment of patent costs	-154	0
Payment of website development costs	-8	0
Proceeds from disposal of long-lived assets	0	18
Net cash used in investing activities	-468	-783
Cash flows from financing activities:	'	'
Net proceeds from line of credit	150	3,600
Repayment of long term notes payable	-1,437	-1,646
Principal payments on capital lease obligations	-11	-11
Proceeds from issuance of Series C and Series B preferred stock	2,000	0
Proceeds received from warrant exercise	1	0
Payment of preferred stock issuance costs	-321	0
Payment in connection with legal settlement agreement	-1,465	0
Payment of debt issuance and deferred financing costs	-21	0
Net cash (used in) provided by financing activities	-1,104	1,943
Effect of exchange rate changes on cash	-38	32
Net decrease in cash	-17	-1,088
Cash, beginning of period	865	2,695
Cash, end of period	$848	$1,607

ORGANIZATION

ORGANIZATION	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
ORGANIZATION	'
	1	ORGANIZATION
	Cyalume Technologies Holdings, Inc. (the “Company”) was organized as a blank check company under the laws of the State of Delaware on July 19, 2005. At that time, the Company was named Vector Security Intersect Acquisition Corp. On December 19, 2008, the Company acquired Cyalume Technologies, Inc. (“CTI”) and changed the corporate name to the current name. CTI is a Delaware corporation formed on March 27, 1997 with headquarters located in Fort Lauderdale, Florida.

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
BASIS OF PRESENTATION	'
	2	BASIS OF PRESENTATION
	The accompanying unaudited condensed consolidated financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading. All the adjustments which, in the opinion of management, are considered necessary for a fair presentation of the results of operations for the periods shown are of a normal recurring nature and have been reflected in the unaudited condensed consolidated financial statements. Results from operations for the three months and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for any other interim period or for the year ending December 31, 2014. The consolidated balance sheet at December 31, 2013 has been derived from the audited consolidated financial statements at that date. The information included in these unaudited interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto in our Annual Report on Form 10-K for the year ended December 31, 2013 filed on April 15, 2014.
	The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. While the Company believes that such estimates are fair when considered in conjunction with the condensed consolidated financial position and results of operations taken as a whole, the actual amount of such estimates, when known, may vary from these estimates.

DESCRIPTION_OF_BUSINESS

DESCRIPTION OF BUSINESS	9 Months Ended
	Sep. 30, 2014
Business Combination, Description [Abstract]	'
DESCRIPTION OF BUSINESS	'
	3	DESCRIPTION OF BUSINESS
	These consolidated financial statements and footnotes include the financial position and operations of Cyalume Technologies Holdings, Inc. (“Cyalume”), a holding company that is the sole shareholder of Cyalume Technologies, Inc. (“CTI”) and of Cyalume Specialty Products, Inc. (“CSP”). CTI is the sole shareholder of Cyalume Technologies, SAS (“CTSAS”), Cyalume Realty, Inc. (“CRI”) and Combat Training Solutions, Inc. (“CTS”). All significant intercompany accounts and transactions have been eliminated in consolidation.
	The Company’s primary focus is providing tactical and training solutions to the military of the U.S. and other countries through both products and services.
	CTI and CTSAS manufacture and sell chemiluminescent products and reflective and photoluminescent materials to military, ammunition, commercial and public safety markets. CTSAS is located in France and represents the Company in certain international markets, primarily Europe and the Middle East. CTI sells to customers in all other geographic markets. CTI’s and CTSAS’ business operations constitute the majority, based on revenues and assets, of the Company’s consolidated business operations.
	CSP manufactures and sells specialty chemical products to the defense, pharmaceutical, cosmetic and other markets. CSP’s operations are located in Bound Brook, New Jersey.
	CRI previously owned land located in Colorado Springs, Colorado. The land was transferred in connection with a 2013 legal settlement.
	CTS provides its customers with battlefield effects simulation products while its services include planning and implementing tactical training exercises simulating real-world experiences. These products allow military and law enforcement professionals to maintain operational readiness through safe, live training and hands-on situational exercises.
	The Company’s business is managed and financial results are reported as one segment. The Company’s CEO, who is the Company’s chief operating decision maker, focuses on consolidated results to make strategic and tactical decisions. The Company’s one operating segment consists of three reporting units: Chemical Light (the operations of CTI and CTSAS), Specialty Products (the operations of CSP) and Other (the operations of CRI and the parent company Cyalume Technologies Holdings, Inc.).
	The Company’s consolidated financial statements have been prepared assuming the Company will continue as a going concern. For the nine months ended September 30, 2014, the Company had a net loss of approximately $7.7 million, and generated approximately $1.6 million of cash in its operations. As of September 30, 2014, the Company had an accumulated deficit of approximately $103.5 million, total stockholders’ equity of approximately $0.5 million and the Company’s unrestricted cash balance was approximately $0.8 million.
	Due to uncertainty about the Company’s ability to meet its current operating expenses and current obligations, in their report on the Company’s annual financial statements for the year ended December 31, 2013, the Company’s independent registered public accounting firm included an explanatory paragraph regarding the Company’s ability to continue as a going concern. The Company’s consolidated financial statements do not include any adjustments relating to the recoverability of assets and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.
	Management continues to evaluate various possibilities including but not limited to refinancing or restructuring the Company’s debt, reducing or eliminating operating expenses, and raising additional capital through the issuance of common or preferred stock or securities convertible into common stock. These possibilities, to the extent available, may be on terms that result in significant dilution to the Company’s existing stockholders, may reduce the value of the stockholders’ investment in the Company or may impact the Company’s stock price. On July 30, 2014, the Company entered into a Securities Purchase Agreement with Cova Small Cap Holdings, LLC (“Cova”), Bayonet Capital Fund I, LLC (“Bayonet”) (see Note 9) and another investor for the purchase of an aggregate of 1,000 units of securities of the Company for an aggregate purchase price of $2.0 million (see Note 14). Cova is a significant stockholder of the Company. Two members of the Board are affiliated with, and designees of, Cova.  Bayonet is controlled by James Schleck, a member of the Company’s Board of Directors (the Board”) and a significant Stockholder of the Company.

IMPAIRMENT_CHARGES

IMPAIRMENT CHARGES	9 Months Ended
	Sep. 30, 2014
Asset Impairment Charges [Abstract]	'
IMPAIRMENT CHARGES	'
	4	IMPAIRMENT CHARGES
	During the third quarter of 2014, the Company’s Chemical Light reporting unit recorded a loss on impairment of certain amortizing intangible assets of $9.1 million. See Note 12 for fair value information on these assets.
	During the third quarter of 2014, management conducted an annual review of tangible and intangible assets for impairment. Before assessing whether any of the Company’s reporting units’ goodwill was impaired, the Company first assessed whether any long-lived assets were impaired. This assessment determined that the CTI patent asset was impaired by approximately $4.9 million and that CTI trademarks and trade names were impaired by approximately $4.2 million. Therefore, the Company recorded a $9.1 million impairment loss on these CTI intangible assets during the third quarter of 2014.
	The “step 1” goodwill impairment assessment was performed by comparing the fair value of each reporting unit containing goodwill to those reporting units’ carrying values. The Company’s Chemical Light and Specialty Products reporting units have goodwill assets. Since there are no quoted market prices for the Company’s reporting units, the fair value of the Company’s reporting units were determined using a discounted present value technique utilizing each reporting unit’s forecasted after-tax cash flows. The “step 1” test determined that the fair value of the both the Chemical Light reporting unit and the Specialty Products reporting unit exceeded its carrying value, and therefore the goodwill did not need to be tested further under what is commonly known as “step 2” of the goodwill impairment assessment.
	Under “step 2” of a goodwill impairment assessment, the implied fair value of a reporting unit’s goodwill is compared with the carrying amount of that goodwill. If the carrying amount of the goodwill exceeds the implied fair value of that goodwill, that excess must be recognized as an impairment loss. The implied fair value of goodwill is determined in the same manner as the amount of goodwill recognized in a business combination. The excess of the fair value of the reporting unit over the amounts assigned to its assets and liabilities is the implied amount of a reporting unit’s goodwill. Intangible assets are identified and valued during this process, such as customer relationships, patents, trade names, non-compete agreements, and the Company’s workforce.

INVENTORIES

INVENTORIES	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
INVENTORIES	'
	5	INVENTORIES
	Inventories consist of the following (all amounts in thousands) :
			September 30,		December 31,
			2014		2013
	Raw materials		$	5,277	$	6,535
	Work-in-process			1,803		2,185
	Finished goods			2,041		2,062
			$	9,121	$	10,782

CREDIT_LINE_AND_NOTES_PAYABLE

CREDIT LINE AND NOTES PAYABLE	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
CREDIT LINE AND NOTES PAYABLE	'
	6	CREDIT LINE AND NOTES PAYABLE
	Line of Credit
	The Company has a line of credit with a maximum borrowing capacity of $5.0 million with TD Bank N.A. (“TD Bank”). The amount which may be borrowed from this line of credit is dependent mainly on accounts receivable and inventory balances. Interest is payable monthly and is determined based on the Prime Rate, plus 3%. The line of credit’s interest rate at September 30, 2014 was 6.25%. The line of credit expires on December 19, 2015. This line of credit is subject to (i) the same restrictive covenants and (ii) the same collateral and guarantees as the senior debt Term Loan and the senior debt Real Estate Loan as described below. At September 30, 2014, $1.8 million was outstanding on this line of credit and borrowing availability was approximately $1.1 million.
	Notes Payable
	Outstanding notes payable consist of (all amounts in thousands):
			September 30,		December 31,
			2014		2013
	Senior Debt - Term Loan		$	4,683	$	6,023
	Senior Debt - Real Estate Loan			1,582		1,679
	Subordinated Term Loan			9,409		8,659
	Promissory Note Payable			860		1,075
	Total			16,534		17,436
	Less: Unamortized debt discount			-390		-542
	Less: Current portion of notes payable, including current portion of unamortized debt discount			-1,893		-1,925
	Notes payable, net of current portion		$	14,251	$	14,969
	Senior Debt
	CTI has two loans payable to TD Bank, a term loan (the “Term Loan”) and a real estate loan (the “Real Estate Loan”), that were originally entered into on December 19, 2008, and which were amended twice during 2012 to modify certain financial and non-financial covenants required by these loans. The Fourth Amendment to the Amended and Restated Revolving Credit and Term Loan Agreement (the “Senior Amendment”) was entered into on November 19, 2013.
	The Term Loan is payable in monthly principal installments of $148,000 along with monthly interest payments, plus a one-time principal payment of approximately $2.5 million due at maturity in December 2015. The Real Estate Loan is payable in monthly principal installments of approximately $10,000, along with monthly interest payments, plus a one-time principal payment of $1.4 million due at maturity in December 2015.
	The TD Bank line of credit, the Term Loan and the Real Estate Loan are senior in payment priority to all other notes payable and lines of credit.
	Subordinated Term Loan
	On July 29, 2010, the subordinated term loan of $8.5 million (the “Subordinated Term Loan”)  was issued to Granite Creek Partners Agent, LLC (“Granite Creek”) and on November 19, 2013, the Company entered into a Fourth Amendment to the Subordinated Term Loan (the “Subordinated Amendment”) which extended the maturity date to June 30, 2016. Pursuant to the Subordinated Amendment, interest is payable in kind through December 19, 2015 and then payable monthly in cash through the June 30, 2016 maturity date. Interest is payable monthly at a rate of 11% per annum. No principal payments are required until maturity. The Company has the right to prepay the loan in whole or in part at any time without penalty in the event that the Company’s indebtedness with TD Bank is repaid. The Subordinated Term Loan ranks junior to all debt held by TD Bank but senior to all other remaining long-term debt including existing and future subordinated debt. The Subordinated Term Loan is convertible at any time by Granite Creek into 2,666,667 shares of common stock at a conversion price of approximately $3.19 per share. No portion of the Subordinated Term Loan has been converted to our common stock. The Company previously determined that the convertible notes’ conversion feature was not a beneficial conversion feature under U.S. GAAP. Simultaneous with the issuance of the Subordinated Term Loan during 2010, the Company issued warrants (the “Subordinated Term Loan Warrants”) to repay certain costs of obtaining the convertible notes. These warrants initially allowed the holder to purchase 160,000 shares of common stock at $1.50 per share through July 19, 2018. A portion of the $8.5 million gross proceeds from the issuance of the loan was allocated to the warrants based on the relative fair values of the debt instrument without the warrants and of the warrants themselves at time of issuance. The portion of the proceeds so allocated to the warrants ($207,000) was recorded as a debt discount and an increase to additional paid-in capital on our consolidated balance sheet. The warrant’s fair value was increased by $94,000 in 2012 due to (i) a decrease in the exercise price of the warrants and (ii) an extension of the term of the warrant. The Subordinated Term Loan Warrants were amended again during 2013 in connection with the Senior Amendment described above. An additional amount was added to debt discount and warrant liability during 2013 relating to (i) another decrease in the exercise price of the warrants to $0.01, (ii) an extension of the term of the warrants, and (iii) an increase to the number of shares of common stock that may be purchased upon exercise of the warrants to 455,514 shares of common stock. The debt discount is being amortized to interest expense using the effective interest method over the life of the convertible notes which have a maturity date of June 30, 2016. As a result of the amendment to the warrants, the warrants are no longer indexed to the Company’s stock, are considered a derivative and therefore, are being accounted for as a liability.

PREFERRED_STOCK_AND_STOCK_WARR

PREFERRED STOCK AND STOCK WARRANTS	9 Months Ended
	Sep. 30, 2014
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]	'
PREFERRED STOCK AND STOCK WARRANTS	'
	7	PREFERRED STOCK AND STOCK WARRANTS
	Series A Convertible Preferred Stock
	The Company is authorized to issue 1,000,000 shares of preferred stock in one or more series with such designations, voting and other rights and preferences as may be determined from time to time by our Board of Directors.
	On November 19, 2013, the Company entered into a Securities Purchase Agreement (the “Series A Purchase Agreement”) with US VC Partners, L.P. (the “Series A Investor”) for the purchase by the Investor of 123,077 units of securities of the Company for an aggregate purchase price of $4.0 million (or $32.50 per unit). Each security issued is comprised of: 1) one share of Series A Convertible Preferred Stock of the Company, at a par value of $0.001 per share (the “Series A Preferred Stock”); 2) one common stock warrant ( the “Common Warrant”); and 3) one preferred stock warrant (the “Preferred Warrant”).
	Each share of Series A Preferred Stock may be converted at any time at the option of the holder into a number of shares of common stock initially equal to 50 shares of common stock, determined by dividing the Liquidation Value per share of Series A Preferred Stock by the applicable conversion price per share of Series A Preferred Stock. The initial conversion price was equal to $0.65, subject to customary adjustments, including for any accrued but unpaid dividends and pursuant to certain anti-dilution provisions. Pursuant to the Series A Certificate of Designation amended on July 30, 2014 (the “Amended Series A Certificate of Designation”), the conversion price per share of Series A Preferred Stock is now equal to $0.13664587. The Series A Preferred Stock is not subject to mandatory conversion at any time.
	Since the Common Warrant and the Preferred Warrant were not indexed to the Company’s stock, they were derivatives and therefore, were being accounted for as a liability. The Common Warrant and the Preferred Warrant were both terminated on July 30, 2014 in connection with the issuance of the Series B Convertible Preferred Stock and the Series C Preferred Stock discussed below. The warrants were marked to their market value of approximately $1.5 million as of July 30, 2014, at which time the liability was reclassified to equity.
	Upon voluntary or involuntary liquidation, dissolution or winding up of the Company, each holder of Series A Preferred Stock is entitled to a liquidation preference of $32.50 per share, plus any accrued but unpaid dividends, subject to customary adjustments as set forth in the Certificate of Designation (the “Series A Liquidation Value”).
	Dividends on the Series A Preferred Stock accrue (payable in cash or in kind), whether or not declared by the Board and whether or not funds are available for the payment of dividends, at a rate of 12% per annum on the sum of the liquidation preference plus all accrued and accumulated dividends and will be payable quarterly in arrears in a) cash or b) newly issued shares of Series A Preferred Stock having an aggregate liquidation preference equal to the amount of such accrued dividends (“PIK Dividends”) at the option of the Company. All accrued and accumulated dividends on the convertible preferred stock shall be paid prior to and in preference to any other class of securities of the Company.
	Each share of Series A Preferred Stock will be entitled to a number of votes equal to the number of shares of common stock into which such share is convertible and shall be entitled to vote with holders of outstanding shares of common stock, voting together as a single class, with respect to any and all matters presented to the stockholders of the Company for their action or consideration.
	The requisite holders of the Series A Preferred Stock will have the right to cause the Company to redeem, out of funds legally available, all but not less than all of the then outstanding shares of Series A Preferred Stock, for a price per share equal to the Series A Liquidation Value of such shares from and after the fifth anniversary of the closing date of the Series A Purchase Agreement. Additionally, the Company will have the right to redeem all of the outstanding shares of Series A Preferred Stock from and after the eighth anniversary of the closing date of the Series A Purchase Agreement at a redemption price equal to the Series A Liquidation Value. As a result of the redemption provisions, the Series A Preferred Stock has been classified outside of permanent equity.
	The significant change in the conversion price of the Series A Preferred Stock was determined to be a substantive qualitative change of a conversion feature that is reasonably possible of being exercised. Therefore, the amendment to the terms of the Series A Preferred Stock made on July 30, 2014 was accounted for as an extinguishment in accordance with the derecognition accounting model under ASC 260-10-S99-2. The Series A Preferred Stock fair value on the extinguishment date was estimated at approximately $1.6 million. This resulted in the Company recognizing a deemed dividend of approximately $2.4 million to reflect the Series A Preferred Stock at its July 30, 2014 redemption value.
	Series B Convertible Preferred Stock
	On July 30, 2014, the Company entered into a Securities Purchase Agreement (the “Series Band C Purchase Agreement”) with Cova Small Cap Holdings, LLC (“Cova”), Bayonet Capital Fund I, LLC (see Note 9), and another investor (each, an “Investor”) for the purchase by the Investors of an aggregate of 1,000 units of securities of the Company (the “Units”) for an aggregate purchase price of $2.0 million (or $2,000.00 per Unit), with each Unit comprising (1) one share of Series B Convertible Preferred Stock of the Company, par value $0.001 per share (the “Series B Preferred Stock”), and (2) one share of Series C Preferred Stock of the Company, par value $0.001 per share (the “Series C Preferred Stock”). Approximately $1.3 million of the net proceeds from the sale of the Units was used to pay a contingent legal obligation pursuant to Civil Action No. 06-706 (see Note 11).
	The shares of Series B Preferred Stock have the rights and preferences set forth in the Certificate of Designation of Series B Convertible Preferred Stock (the “Series B Certificate of Designation”). Pursuant to the Series B Certificate of Designation, each share of Series B Preferred Stock ranks senior to the Company’s common stock (the “Common Stock”) and the Company’s Series A Preferred Stock with respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company. Upon the Company’s liquidation, sale to or merger with another corporation or other “Change of Control” (as such term is defined in the Series B Certificate of Designation), each share of Series B Preferred Stock would be entitled to a liquidation preference in an amount equal to the amount per share that would have been payable had all shares of Series B Preferred Stock been converted into Common Stock immediately prior to such event in accordance with the terms of the Series B Certificate of Designation, excluding for purposes of such calculation the liquidation preference payable to the holders of Series A Preferred Stock. Holders of the Series B Preferred Stock are entitled to convert at any time all or any portion of the shares of Series B Preferred Stock into a number of shares of Common Stock initially equal to 35,713.147 shares of Common Stock per share of Series B Preferred Stock (the “Conversion Number”), such that the 1,000 shares of Series B Preferred Stock issued pursuant to the Purchase Agreement will initially be convertible into a number of shares of Common Stock representing approximately 40% of the total number of shares of Common Stock outstanding, calculated on a fully-diluted basis, assuming the conversion of all outstanding shares of Series A Preferred Stock and Series B Preferred Stock. The Conversion Number is subject to customary adjustments, including for dividends, stock splits and other reorganizations affecting the Common Stock. In addition, the Conversion Number is subject to anti-dilution protections, subject to certain exceptions, if the Company issues or sells shares of Common Stock or other equity securities for no consideration or for consideration that is based on an equity valuation of the Company of less than $2 million in the aggregate (a “Trigger Issuance”). In the event of a Trigger Issuance, the Conversion Number shall be increased as of the close of business on the effective date of the Trigger Issuance to a number calculated as follows: (i) two-thirds of the Common Stock deemed Outstanding (as defined in the Series A Certificate of Designation) immediately following such Trigger Issuance (excluding any Common Stock Deemed Outstanding as a result of the conversion of the Series B Preferred Stock) (ii) divided by 1,000. Each share of Series B Preferred Stock will automatically convert into shares of Common Stock on the tenth anniversary of its original issuance date, at the then-current Conversion Number. Each share of Series B Preferred Stock is entitled to a number of votes equal to the number of shares of Common Stock into which such share is convertible and will be entitled to vote with holders of outstanding shares of Common Stock, voting together as a single class, with respect to any and all matters presented to the stockholders of the Company for their action or consideration.
	In connection with the issuance of the Series B Preferred Stock and the Series C Preferred Stock on July 30, 2014, the Company allocated the aggregate proceeds of $2.0 million to the Series B Preferred Stock and the Series C Preferred Stock on a relative fair value basis. This resulted in approximately $1.4 million allocated to the Series B Preferred Stock and approximately $0.6 million allocated to the Series C Preferred Stock.
	At the issuance date, the Series B Preferred Stock is convertible into Common Stock having a fair value of approximately $2.5 million, which was in excess of the proceeds allocated to the Series B Preferred Stock. Therefore, the Company recognized a beneficial conversion feature of approximately $1.1 million in accordance with ASC 470-20. This initially recorded discount was then accreted back to its carrying value of the Series B Preferred Stock as the stock is immediately convertible at the option of the holder.
	Series C Preferred Stock
	The shares of Series C Preferred Stock have the rights and preferences set forth in the Certificate of Designation of Series C Preferred Stock (the “Series C Certificate of Designation”). Pursuant to the Series C Certificate of Designation, each share of Series C Preferred Stock ranks senior to the Common Stock, the Series A Preferred Stock and the Series B Preferred Stock with respect to payment of dividends and distribution of assets upon liquidation, dissolution or winding up of the Company. Upon the Company’s liquidation, sale to or merger with another corporation or other “Change of Control” (as such term is defined in the Series C Certificate of Designation), each share of Series C Preferred Stock would be entitled to a liquidation preference equal to the greater of (1) $3,000 per share or (2) $2,000 per share plus any accrued but unpaid dividends, in each case subject to customary adjustments as set forth in the Series C Certificate of Designation (the “Series C Liquidation Value”). The Series C Liquidation Value is the greater of (1) 150% of the Purchase Price ($3,000 per share) or (2) the Base Value ($2,000 per share plus accrued and unpaid dividends). Holders of the Series C Preferred Stock are entitled to cumulative quarterly dividends at a rate of 12% per annum, calculated based on an assumed price of $2,000 per share, payable in cash or in kind; provided that to the extent not paid in cash or by issuance of additional shares of Series C Preferred Stock on the last day of each calendar quarter (a “Dividend Payment Date”), all accrued dividends on any outstanding shares of Series C Preferred Stock shall accumulate and compound. In the event the Company has not paid in cash or by the issuance of additional shares of Series C Preferred Stock all accrued dividends on a Dividend Payment Date, at the election of holders of at least 75% of the outstanding shares of Series C Preferred Stock (the “Requisite Holders”), all such dividends accruing on the shares of Series C Preferred Stock will be paid in shares of Series C Preferred Stock. From and after the fifth anniversary of the issuance of the shares of Series C Preferred Stock, the Requisite Holders will have the right to elect to cause the Company to redeem, out of funds legally available therefore, all but not less than all of the then outstanding shares of Series C Preferred Stock, for a price per share equal to the Series C Liquidation Value for such shares. In addition, the Company has the right to redeem at any time, out of funds legally available therefor, all or any portion of the then outstanding shares of Series C Preferred Stock, for a price per share equal to the Series C Liquidation Value for such shares. The Series C Preferred Stock is not convertible into Common Stock or other securities of the Company, and does not have any voting rights.
	The proceeds allocated to the Series C Preferred Stock fair on the issuance date were estimated at approximately $0.6 million. This resulted in the Company recognizing a deemed dividend of approximately $1.4 million to reflect the Series C Preferred Stock at its July 30, 2014 redemption value.
	Common and Preferred Warrants
	In connection with the Series A Preferred Stock issued on November 19, 2013, the Company also issued a Common Warrant for the purchase of up to 6,153,830 shares of common stock at an exercise price of $0.65 per share. This warrant was terminated on July 30, 2014. The change in the estimated fair value of the Common Warrant is reflected within the “Change in fair value of warrants liability” within the accompanying consolidated statements of comprehensive loss.
	The fair value as of July 30, 2014 (prior to the termination of the Common Warrant) and December 31, 2013, respectively, of the Common Warrant was estimated using the Monte Carlo simulation method with the following inputs:
			Common				Common
			Warrant				Warrant
			July 30,				December 31,
			2014				2013
	Stock price of underlying equity		$	0.07			$	0.69
	Exercise price		$	0.65			$	0.65
	Expected volatility (standard deviation)			100	%			100	%
	Annual risk-free rate			2.49	%			3.04	%
	Expected term (time to expiration years)			9.3				9.9
	Number of periods			485				514
	Period interval			0.019				0.019
	Period risk-free rate			0.048	%			0.058	%
	Number of simulations			500,000				500,000
	In connection with the Series A Preferred Stock issued on November 19, 2013, the Company also issued a Preferred Warrant for the purchase of up to 123,077 shares of Series A Preferred Stock with an exercise price of $0.05 per share. This warrant was terminated on July 30, 2014. The change in the estimated fair value of the Preferred Warrant is reflected within the “Change in fair value of warrants liability” within the accompanying statements of comprehensive loss.
	The fair value as July 30, 2014 (prior to the termination of the Preferred Warrant) and December 31, 2013, respectively, of the Preferred Warrant was estimated using the Black-Scholes pricing model with the following inputs:
			Preferred				Preferred
			Warrant				Warrant
			July 30,				December 31,
			2014				2013
	Stock price of underlying equity		$	12.63			$	32.5
	Exercise price		$	0.05				0.05
	Expected term (years)			1.17				1.7
	Risk-free interest rate			0.2	%			0.13	%
	Estimated dividend yield			None				None
	Volatility			70	%			70	%
	The change in the fair value of the warrants liability during the nine months ended September 30, 2014 is as follows (amounts in thousands):
			Common			Preferred			JFC Warrant		Subordinated		Total Warrant
			Warrant			Warrant			(see Note 9)		Term Loan		Liability
											Warrants (see
											Note 6)
	Warrant liability at December 31, 2013		$	4,081		$	1,997		$	54	$	241	$	6,373
	Warrants amended in connection with refinancing			0			0			0		72		72
	Warrant exercise			0			0			-44		0		-44
	Change in fair value of warrants			-3,331			-1,223			-10		-280		-4,844
	Termination of Common and Preferred Warrants			-750			-774			0		0		-1,524
	Warrant liability at September 30, 2014		$	0		$	0		$	0	$	33	$	33

INCOME_TAXES

INCOME TAXES	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	8	INCOME TAXES
	The effective tax rate for the three months ended September 30, 2014 was approximately (1%) and the effective tax rate for the three months ended September 30, 2013 was approximately 20%, compared to the federal statutory rate of 34%. The effective tax rates for the nine months ended September 30, 2014 and September 30, 2013 were approximately (4%) and 24%, respectively, compared to the federal statutory rate of 34%. During the three and nine months ended September 30, 2014, the Company incurred approximately $112,000 and $269,000 of foreign tax expense on CTSAS’ income. The Company continues to have a full valuation allowance against its U.S. deferred tax assets. The Company has a valuation allowance of approximately $9.0 million as of September 30, 2014 against deferred tax assets generated primarily as a result of foreign tax credits and net operating losses.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
RELATED PARTY TRANSACTION	'
	9	RELATED PARTY TRANSACTIONS
	Financing Arrangements and Agreements with Related Parties
	In December 2012, the Company entered into a $2,100,000 unsecured promissory note with JFC Technologies, LLC (“JFC”), an entity controlled by James Schleck, a previous employee of CSP who is an owner of a significant amount of the Company’s common shares and is a Board member. On November 19, 2013, the unsecured promissory note was amended (the “Amended JFC Note”). Pursuant to the Amended JFC Note, interest accrues on the principal amount at the rate of 12% per annum, retroactive to the date of the original note. The entire principal amount and all accrued interest under the Amended JFC Note is due on the maturity date of December 31, 2016, or upon the refinancing of the Company’s existing indebtedness (subject to the availability of at least $5,000,000 in available credit after such repayment). Pursuant to the Amended JFC Note, up to $1.0 million of the principal amount is convertible, at the option of JFC, into the number of shares of Series A Preferred Stock equal to the portion of the principal amount being converted divided by the conversion price of $32.50 per share (subject to adjustment based on certain changes in capitalization affecting the Series A Preferred Stock). In addition, upon conversion of the first $499,980 of Amended JFC Note principal, JFC originally would have been entitled to receive: (1) warrants to purchase, for each $6.50 of principal amount converted, ten shares of the Company’s common stock, and (2) warrants to purchase for each $32.50 of principal amount converted, one share of Series A Preferred Stock.
	In connection with the issuance of the Series B Convertible Preferred Stock and the Series C Preferred Stock (see Note 7), the Series A Investor and JFC entered into a Consent and Waiver Agreement with the Company, whereby the Series A Investor agreed to the termination of all of the warrants issued to it in connection with the Series A Preferred Stock and JFC agreed to terminate any right of JFC to receive any warrants otherwise issuable to it upon the conversion of any portion of the JFC Note pursuant to the terms thereof.
	In accordance with ASC 470-50-40-10, the Company analyzed the Amended JFC Note and determined that the change in the conversion price of the Series A Preferred Stock was substantive. Therefore, the amendment to the terms of the JFC Note on July 30, 2014 resulted in a loss on extinguishment of approximately $0.5 million.
	On November 19, 2013, the Company also issued a warrant to JFC to purchase up to 73,009 shares of the Company’s common stock. These warrants have an exercise price of $0.01 and expire on November 19, 2023. The warrant was exercised by JFC during February 2014.
	Bayonet Capital Fund I, LLC and JFC are controlled by James Schleck, a member of the Company’s board of directors, and JFC is also a significant stockholder of the Company.
	The Company also entered into a consulting agreement with James Schleck, effective January 1, 2014, for advisory professional services as assigned by the President and CEO or the Board of Directors of the Company. The initial consulting agreement provided for monthly fees payable to James Schleck of $1,000 monthly and the consulting agreement was amended effective June 1, 2014 to provide for monthly fees in the amount of $10,000 monthly. This consulting agreement was terminated effective September 30, 2014.
	CSP leases property in Bound Brook, New Jersey, from Brook Industrial Park, LLC, an entity that is controlled by James Schleck. This lease requires monthly lease payments of $30,000 and ends on August 31, 2016, with extension options available.
	Pursuant to an Amendment Agreement executed during December 2012, the Company was required to issue 350,000 shares of the Company’s common stock to JFC if the Company’s December 2013 common stock closing price was less than $1.75. The Company’s closing price on December 31, 2013 was $0.69 and therefore, the Company recorded approximately $242,000 within other current liabilities during 2013 and the 350,000 shares were issued to JFC on January 31, 2014.
	Agreement with Board Member
	On October 1, 2009, the Company entered into an agreement with Selway Capital, LLC (“Selway”) that provided for services to be performed by Selway on the Company’s behalf. This agreement was terminated effective March 31, 2014. The agreement previously stipulated that these services would be performed by Yaron Eitan, an employee of Selway and a member of the Company’s Board of Directors, with assistance, as needed, from other employees of Selway. Effective January 1, 2014, compensation for these services was $11,000 monthly. During April 2014, approximately $158,000 of 2013 Selway fees was settled by issuing 242,308 shares of the Company’s common stock

NET_LOSS_PER_COMMON_SHARE

NET LOSS PER COMMON SHARE	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
NET LOSS PER COMMON SHARE	'
	10	NET LOSS PER COMMON SHARE
	Basic loss per common share is computed by dividing net loss available to common stockholders by the basic weighted average number of common shares outstanding. Diluted loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares and dilutive potential common share equivalents then outstanding. Potential common share equivalents consist of (i) shares issuable upon the exercise of warrants and options (using the “treasury stock” method), (ii) unvested restricted stock awards (using the “treasury stock” method) and (iii) shares issuable upon conversion of convertible instruments using the “if-converted” method.
			Three Months Ended				Nine Months Ended
			September 30,				September 30,
			2014		2013		2014		2013
	Numerator (in thousands):
	Net loss		$	-10,273	$	-7,804	$	-7,675	$	-9,662
	Series A convertible preferred stock accrued dividend			-130		0		-375		0
	Series C preferred stock accrued dividend			-41		0		-41		0
	Series A deemed dividend			-2,422		0		-2,422		0
	Series B deemed dividend			-1,098		0		-1,098		0
	Series C deemed dividend			-1,401		0		-1,401		0
	Loss available to common stockholders – basic and diluted		$	-15,365	$	-7,804	$	-13,012	$	-9,662
	Loss per common share:
	Basic and diluted		$	-0.72	$	-0.38	$	-0.61	$	-0.47
	The following potentially dilutive common share equivalents were excluded from the calculation of diluted net loss per common share because their effect was antidilutive for each of the periods presented:
			Three Months Ended September 30,				Nine Months Ended September 30,
			2014		2013		2014		2013
	Options			2,636,186		3,226,186		2,636,186		3,226,186
	Restricted stock			0		23,024		0		22,704
	Convertible debt			2,666,667		2,666,667		2,666,667		2,666,667
	Warrants			455,514		0		455,514		0

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	11	COMMITMENTS AND CONTINGENCIES
	Legal
	Civil Action No. 06-706 in Superior Court of the Commonwealth of Massachusetts
	On January 23, 2006, before the Company owned CTI, the former owners of CTI (from whom CTI was purchased) (the “Former Owners”) acquired all of the outstanding capital stock of Omniglow Corporation (the “Transaction”) and changed the name of the company to Cyalume Technologies, Inc. Prior to, or substantially simultaneously with, the Transaction, CTI sold certain assets and liabilities related to Omniglow Corporation’s novelty and retail business to certain former Omniglow Corporation stockholders and management (“the Omniglow Buyers”). This was done because CTI sought to retain only the Omniglow Corporation assets and current liabilities associated with its government, military and safety business. During 2006, CTI and the Omniglow Buyers commenced litigation and arbitration proceedings against one another. Claims include breaches of a lease and breaches of various other agreements between CTI and the Omniglow Buyers. These proceedings are known as Civil Action No. 06-706 in Superior Court of the Commonwealth of Massachusetts (the “Court”).
	On December 19, 2008, while Civil Action 06-706 was still unresolved, the Company acquired CTI (the “Acquisition”). According to the Stock Purchase Agreement between the Former Owners and the Company, the Former Owners retained the responsibility for paying for all costs and liabilities associated with Civil Action No. 06-706.
	On July 18, 2011, CTI received an Order for Entry of Final Judgment in Civil Action No. 06-706 in which the Court awarded approximately $2.6 million in damages to Omniglow, LLC. Prejudgment interest at the rate of twelve (12%) percent per annum since the filing of the complaint in 2006 accrues on approximately $1.3 million of the damages. The Court also awarded Omniglow, LLC reimbursement of attorney fees and costs of approximately $235,000, on which interest at the rate of twelve (12%) percent per annum accrues beginning with the date of the final ruling.
	On July 12, 2012, the Court issued an Amended Final Judgment and, on September 20, 2012, a Final Judgment. There were no changes to the previously described damage awards. In response, on October 17, 2012, the Company filed a Notice of Appeal and on August 2, 2013, the Company filed a Formal Appeal, which contained a number of bases for overturning the awards. Oral arguments were made by the parties before the Appellate Court during January of 2014. In May 2014, the Company received notice that its appeal of the Final Judgment had been denied. On July 1, 2014, CTI filed an Application for Further Appellate Review in the Massachusetts Supreme Judicial Court.
	The Former Owners (1) previously retained the responsibility for paying the costs and liabilities associated with Civil Action No. 06-706 and (2) are related parties under U.S. GAAP due to their ownership interest in the Company and their membership on the Company’s board of directors. On November 19, 2013, a Release and Escrow Agreement was executed whereby the Company released affiliates of the Former Owners from being obligated on the costs and liabilities associated with Civil Action No. 06-706 in exchange for 625,139 shares of Cyalume stock placed in escrow (the “Escrowed Shares”). During 2013, 625,139 shares of the Company’s common stock were placed into escrow which were applied against any damages during July 2014 up to the value of the shares upon conversion to cash. The Escrowed Shares provided the Company with a source of recovery with respect to any loss, liability or expenses incurred by the Company in connection with Civil Action No. 06-706. The Company reflected the value of the 625,139 Escrowed Shares at December 31, 2013 based upon the close price of Cyalume’s stock on December 31, 2013. The value of the Escrowed Shares was previously included within the prepaid expenses and other current assets line item.  The Escrow Shares were transferred during July 2014 in connection with the Confidential Settlement Agreement and Mutual Release discussed below.
	On July 10, 2014, the Company entered into a Confidential Settlement Agreement and Mutual Release (the “Omniglow Settlement Agreement”) with the Former Owners and members of management of Omniglow Corporation (collectively, the “Omniglow Buyers”). Pursuant to the Omniglow Settlement Agreement, CTI agreed to either pay the full settlement amount of approximately $4.5 million or satisfy the settlement amount as follows: (i) an initial payment of $250,000, (ii) transfer the 625,139 Escrowed Shares, (iii) payment of $1.0 million in cash within 21 days from the execution of the Omniglow Settlement Agreement (see Note 14) and (iv) additional payments in cash and/or through cooperative marketing credits of $1.9 million if paid within 18 months from the date of the Omniglow Settlement Agreement, or of approximately $2.4 million if paid within 27 months from the date of the Omniglow Settlement Agreement. During July 2014, the Company fulfilled its obligations under items (i), (ii) and (iii) described above. Approximately $2.7 million of obligations related to this matter is included within the contingent legal obligation line items on the Company’s condensed consolidated balance sheet as of September 30, 2014.
	Settlement of Arbitration with Former Employee
	On December 22, 2011, CTI entered into a Stock Purchase Agreement (“SPA”) with Combat Training Solutions, Inc. (“CTS”) and Antonio Colon, the sole stockholder of CTS. Pursuant to the SPA, CTI purchased all of the issued and outstanding capital stock of CTS. On June 15, 2012, the Company received a copy of a demand for arbitration filed by Mr. Colon with the American Arbitration Association. Management considered the allegations by Mr. Colon to be without merit. On August 17, 2012, Mr. Colon filed suit in Federal Court and on September 11, 2012, he filed to have the arbitration withdrawn. In addition, on September 11, 2012, Mr. Colon chose to cease working for the Company. CTI filed a Motion to Dismiss the Complaint in Federal Court and to compel the controversy to arbitration before the American Arbitration Association. The District Court for the District of Delaware held a hearing on January 23, 2013, at which it dismissed the Complaint in Federal Court without prejudice and indicated that the arbitration should proceed. On September 23, 2013, the parties entered into an agreement to resolve this matter, and a settlement agreement was signed on November 19, 2013. The executed settlement agreement calls for the Company to make a series of payments over five years to Mr. Colon in the amount of $215,000 annually, for a total of $1,075,000 pursuant to the Promissory Note executed on November 19, 2013. The Company also made a settlement payment of $275,000 on November 20, 2013 and transferred the land located in Colorado (this land was originally acquired by CTI in connection with the 2011 CTS acquisition) to JasperCo, LLC pursuant to the terms of the executed settlement agreement with Antonio Colon. The total legal settlement amount recorded in the Company’s accompanying consolidated statement of comprehensive loss for the twelve months ended December 31, 2013 incurred in connection with settling the matter described above was approximately $2.0 million. Pursuant to the Promissory Note, a principal repayment of approximately $215,000 was made during the nine months ended September 30, 2014

FAIR_VALUES_OF_ASSETS_AND_LIAB

FAIR VALUES OF ASSETS AND LIABILITIES	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
FAIR VALUES OF ASSETS AND LIABILITIES	'
	12	FAIR VALUES OF ASSETS AND LIABILITIES
	Under U.S. GAAP, the Company is required to record certain financial assets and liabilities at fair value and may choose to record other financial assets and financial liabilities at fair value as well. Also under U.S. GAAP, “the Company” required to record nonfinancial assets and liabilities at fair value due to events that may or may not recur in the future, such as an impairment event. When “the Company” required to record such assets and liabilities at fair value, that fair value is estimated using an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. That fair value is determined based on significant inputs contained in a fair value hierarchy as follows:
	Level 1	Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.
	Level 2	Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
	Level 3	Unobservable inputs for the asset or liability.
	The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
	There are three general valuation techniques that may be used to measure fair value, as described below:
	Market Approach	Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. Prices may be indicated by pricing guides, sale transactions, market trades, or other sources.
	Cost Approach	Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost).
	Income Approach	Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about the future amounts (includes present value techniques and option-pricing models).
		Net present value is an income approach where a stream of expected cash flows is discounted at an appropriate market interest rate.
	Assets and Liabilities Measured at Fair Value on a Recurring Basis
	Assets and liabilities itemized below were measured at fair value on a recurring basis at September 30, 2014 (all amounts in thousands):
			Level 1		Level 2		Level 3		Assets/
			Quoted		Significant		Significant		(Liabilities)
			Prices in		Other		Unobservable		At Fair
			Active		Observable		Inputs		Value
			Markets		Inputs
			for
			Identical
			Assets
	Warrants (see Note 6) (1)		$	0	$	0	$	-33	$	-33
			$	0	$	0	$	-33	$	-33
		-1	The Company has classified its warrants liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model.
	The Company did not transfer any assets or liabilities between Levels 1, 2 or 3 during the three and nine months ended September 30, 2014. Any such transfer would be based on a review of the inputs used that are significant to the fair value measurement of that asset or liability.
	The Company has other financial instruments, such as cash, accounts receivable, other current assets, accounts payable, notes payable and a line of credit. The Company believes the carrying amounts of those assets and liabilities approximate their fair value since the Company has estimated those carrying amounts to approximate the exit price we would receive to sell these assets or pay to transfer these liabilities to a market participant.
	Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
	During the three months ended September 30, 2014, the following assets, all of which are Level 3 assets, were identified as impaired and were adjusted to their fair values (in thousands of dollars) (see Note 4).
			Cyalume Reporting		Loss Recognized		Fair Value
			Unit (1)
	Patents (2)		Training		$	4,877	$	2,700
	Trademarks and trade name (3)		Training		$	4,223	$	790
		-1	The Company is managed as one operating segment with three reporting units: Chemical Light (the operations of CTI and CTSAS), Specialty Products (the operations of CSP) and Other (the operations of CRI and the parent company Cyalume Technologies Holdings, Inc.). Both Chemical Lights’ goodwill and Specialty Products’ goodwill was not considered to be impaired and our Other reporting unit does not have a goodwill asset.
		-2	The fair value of the impaired patent asset was determined using the “relief from royalty” method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the patents, net of estimated income taxes (an income approach).
		-3	The fair value of the impaired trademarks and trade names asset was determined using the “relief from royalty” method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the trademarks and trade names, net of estimated income taxes (an income approach).

SUPPLEMENTAL_DISCLOSURE_OF_CAS

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	9 Months Ended
	Sep. 30, 2014
Supplemental Cash Flow Elements [Abstract]	'
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	'
	13	SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
	Cash Paid for Interest and Income Taxes (all amounts in thousands) :
			Nine Months Ended September 30
			2014		2013
	Interest		$	456	$	1,250
	Income taxes			171		120
	Non-Cash Investing and Financing Activities (all amounts in thousands) :
			Nine Months Ended September 30,
			2014		2013
	Series A Convertible Preferred stock accrued dividend		$	375	$	0
	Series C Preferred stock accrued dividend			41		0
	Litigation award payable accounted for as a receivable due from related party			0		134
	Adjustment to warrant liability upon warrant exercise			44		0
	Issuance of 350,000 shares to JFC in connection with settling a contingent consideration liability resulting from the acquisition of CSP			241		0
	Issuance of 242,308 shares to Selway			157		0

NEW_ACCOUNTING_PRONOUNCEMENTS

NEW ACCOUNTING PRONOUNCEMENTS	9 Months Ended
	Sep. 30, 2014
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]	'
NEW ACCOUNTING PRONOUNCEMENTS	'
	14	NEW ACCOUNTING PRONOUNCEMENTS
	The following are recent accounting pronouncements that have affected the Company’s consolidated financial statements or may affect them in the future.
	In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. ASU 2014-09 requires recognition of revenue when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five-step process in which judgments and estimates may be required within the revenue recognition process. ASU 2014-09 is effective for annual and interim periods beginning on or after December 15, 2016, permits the use of either a retrospective or a cumulative effect transition method, and early adoption is not permitted. The Company is in the process of evaluating the effect, if any, ASU 2014-09 will have on its consolidated financial statements and related disclosures.
	In July 2013, the FASB issued Accounting Standards Update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry-forward, a Similar Tax Loss, or a Tax Credit Carry-forward Exists (“ASU 2013-11”) to clarify that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss (“NOL”) carry-forward, a similar tax loss, or a tax credit carry-forward, with some allowed exceptions. ASU 2013-11 does not impose any new recurring disclosure requirements because it does not affect the recognition or measurement of uncertain tax positions. ASU 2013-11 is effective for fiscal years beginning after December 15, 2013. The adoption of ASU 2013-11 did not have a material impact on the Company’s financial position or results of operations.

INVENTORIES_Tables

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventory	'
	Inventories consist of the following (all amounts in thousands) :
		September 30,		December 31,
		2014		2013
	Raw materials	$	5,277	$	6,535
	Work-in-process		1,803		2,185
	Finished goods		2,041		2,062
		$	9,121	$	10,782

CREDIT_LINE_AND_NOTES_PAYABLE_

CREDIT LINE AND NOTES PAYABLE (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt	'
	Outstanding notes payable consist of (all amounts in thousands):
		September 30,		December 31,
		2014		2013
	Senior Debt - Term Loan	$	4,683	$	6,023
	Senior Debt - Real Estate Loan		1,582		1,679
	Subordinated Term Loan		9,409		8,659
	Promissory Note Payable		860		1,075
	Total		16,534		17,436
	Less: Unamortized debt discount		-390		-542
	Less: Current portion of notes payable, including current portion of unamortized debt discount		-1,893		-1,925
	Notes payable, net of current portion	$	14,251	$	14,969

PREFERRED_STOCK_AND_STOCK_WARR1

PREFERRED STOCK AND STOCK WARRANTS (Tables)	9 Months Ended
	Sep. 30, 2014
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]	'
Schedule Of Common And Preferred Warrants	'
	The fair value as of July 30, 2014 (prior to the termination of the Common Warrant) and December 31, 2013, respectively, of the Common Warrant was estimated using the Monte Carlo simulation method with the following inputs:
		Common				Common
		Warrant				Warrant
		July 30,				December 31,
		2014				2013
	Stock price of underlying equity	$	0.07			$	0.69
	Exercise price	$	0.65			$	0.65
	Expected volatility (standard deviation)		100	%			100	%
	Annual risk-free rate		2.49	%			3.04	%
	Expected term (time to expiration years)		9.3				9.9
	Number of periods		485				514
	Period interval		0.019				0.019
	Period risk-free rate		0.048	%			0.058	%
	Number of simulations		500,000				500,000
	The fair value as July 30, 2014 (prior to the termination of the Preferred Warrant) and December 31, 2013, respectively, of the Preferred Warrant was estimated using the Black-Scholes pricing model with the following inputs:
		Preferred				Preferred
		Warrant				Warrant
		July 30,				December 31,
		2014				2013
	Stock price of underlying equity	$	12.63			$	32.5
	Exercise price	$	0.05				0.05
	Expected term (years)		1.17				1.7
	Risk-free interest rate		0.2	%			0.13	%
	Estimated dividend yield		None				None
	Volatility		70	%			70	%
Schedule Of Change In The Fair Value Of The Warrants Liability	'
	The change in the fair value of the warrants liability during the nine months ended September 30, 2014 is as follows (amounts in thousands):
		Common			Preferred			JFC Warrant		Subordinated		Total Warrant
		Warrant			Warrant			(see Note 9)		Term Loan		Liability
										Warrants (see
										Note 6)
	Warrant liability at December 31, 2013	$	4,081		$	1,997		$	54	$	241	$	6,373
	Warrants amended in connection with refinancing		0			0			0		72		72
	Warrant exercise		0			0			-44		0		-44
	Change in fair value of warrants		-3,331			-1,223			-10		-280		-4,844
	Termination of Common and Preferred Warrants		-750			-774			0		0		-1,524
	Warrant liability at September 30, 2014	$	0		$	0		$	0	$	33	$	33

NET_LOSS_PER_COMMON_SHARE_Tabl

NET LOSS PER COMMON SHARE (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Net Income Per Common Share	'
	potential common share equivalents then outstanding. Potential common share equivalents consist of (i) shares issuable upon the exercise of warrants and options (using the “treasury stock” method), (ii) unvested restricted stock awards (using the “treasury stock” method) and (iii) shares issuable upon conversion of convertible instruments using the “if-converted” method.
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2014		2013		2014		2013
	Numerator (in thousands):
	Net loss	$	-10,273	$	-7,804	$	-7,675	$	-9,662
	Series A convertible preferred stock accrued dividend		-130		0		-375		0
	Series C preferred stock accrued dividend		-41		0		-41		0
	Series A deemed dividend		-2,422		0		-2,422		0
	Series B deemed dividend		-1,098		0		-1,098		0
	Series C deemed dividend		-1,401		0		-1,401		0
	Loss available to common stockholders – basic and diluted	$	-15,365	$	-7,804	$	-13,012	$	-9,662
	Loss per common share:
	Basic and diluted	$	-0.72	$	-0.38	$	-0.61	$	-0.47
Common Shares Issuable upon Vesting or Exercise of Convertible Securities	'
	The following potentially dilutive common share equivalents were excluded from the calculation of diluted net loss per common share because their effect was antidilutive for each of the periods presented:
		Three Months Ended September 30,				Nine Months Ended September 30,
		2014		2013		2014		2013
	Options		2,636,186		3,226,186		2,636,186		3,226,186
	Restricted stock		0		23,024		0		22,704
	Convertible debt		2,666,667		2,666,667		2,666,667		2,666,667
	Warrants		455,514		0		455,514		0

FAIR_VALUES_OF_ASSETS_AND_LIAB1

FAIR VALUES OF ASSETS AND LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Assets and Liabilities Measured at Fair Value on Recurring Basis	'
	Assets and liabilities itemized below were measured at fair value on a recurring basis at September 30, 2014 (all amounts in thousands):
			Level 1		Level 2		Level 3		Assets/
			Quoted		Significant		Significant		(Liabilities)
			Prices in		Other		Unobservable		At Fair
			Active		Observable		Inputs		Value
			Markets		Inputs
			for
			Identical
			Assets
	Warrants (see Note 6) (1)		$	0	$	0	$	-33	$	-33
			$	0	$	0	$	-33	$	-33
		-1	The Company has classified its warrants liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model.
Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis	'
	During the three months ended September 30, 2014, the following assets, all of which are Level 3 assets, were identified as impaired and were adjusted to their fair values (in thousands of dollars) (see Note 4).
			Cyalume Reporting		Loss Recognized		Fair Value
			Unit (1)
	Patents (2)		Training		$	4,877	$	2,700
	Trademarks and trade name (3)		Training		$	4,223	$	790
		-1	The Company is managed as one operating segment with three reporting units: Chemical Light (the operations of CTI and CTSAS), Specialty Products (the operations of CSP) and Other (the operations of CRI and the parent company Cyalume Technologies Holdings, Inc.). Both Chemical Lights’ goodwill and Specialty Products’ goodwill was not considered to be impaired and our Other reporting unit does not have a goodwill asset.
		-2	The fair value of the impaired patent asset was determined using the “relief from royalty” method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the patents, net of estimated income taxes (an income approach).
		-3	The fair value of the impaired trademarks and trade names asset was determined using the “relief from royalty” method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the trademarks and trade names, net of estimated income taxes (an income approach).

SUPPLEMENTAL_DISCLOSURE_OF_CAS1

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Tables)	9 Months Ended
	Sep. 30, 2014
Supplemental Cash Flow Elements [Abstract]	'
Cash Paid for Interest and Income Taxes	'
	Cash Paid for Interest and Income Taxes (all amounts in thousands) :
		Nine Months Ended September 30
		2014		2013
	Interest	$	456	$	1,250
	Income taxes		171		120
Non-Cash Investing and Financing Activities	'
	Non-Cash Investing and Financing Activities (all amounts in thousands) :
		Nine Months Ended September 30,
		2014		2013
	Series A Convertible Preferred stock accrued dividend	$	375	$	0
	Series C Preferred stock accrued dividend		41		0
	Litigation award payable accounted for as a receivable due from related party		0		134
	Adjustment to warrant liability upon warrant exercise		44		0
	Issuance of 350,000 shares to JFC in connection with settling a contingent consideration liability resulting from the acquisition of CSP		241		0
	Issuance of 242,308 shares to Selway		157		0

DESCRIPTION_OF_BUSINESS_Additi

DESCRIPTION OF BUSINESS - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Jul. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Net Income (Loss) Attributable To Parent	'	($10,273)	($7,804)	($7,675)	($9,662)	'	'
Net Cash Provided By Used In Operating Activities	'	'	'	1,593	-2,280	'	'
Retained Earnings Accumulated Deficit	'	-103,549	'	-103,549	'	-95,874	'
Cash	'	848	1,607	848	1,607	865	2,695
Stockholders Equity	'	485	'	485	'	6,504	'
Series B and Series C preferred stock issued	1,000	'	'	'	'	'	'
Proceeds from issuance of preferred stock	1,300	'	'	2,000	0	'	'
Securities Purchase Agreement [Member]	'	'	'	'	'	'	'
Proceeds from issuance of preferred stock	$2,000	'	'	'	'	'	'

INVENTORIES_Schedule_Of_Invent

INVENTORIES (Schedule Of Inventories) (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Schedule of Inventory [Line Items]	'	'
Raw materials	$5,277	$6,535
Work-in-process	1,803	2,185
Finished goods	2,041	2,062
Inventory, Net	$9,121	$10,782

IMPAIRMENT_CHARGES_Additional_

IMPAIRMENT CHARGES (Additional Information) (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Impairment of Intangible Assets, Finite-lived	$9,100	$0	$9,100	$875
Chemical Light [Member]	'	'	'	'
Impairment of Intangible Assets, Finite-lived	9,100	'	'	'
Trademarks and Trade Names [Member]	'	'	'	'
Impairment of Intangible Assets, Finite-lived	4,200	'	'	'
Patents [Member]	'	'	'	'
Impairment of Intangible Assets, Finite-lived	$4,900	'	'	'

CREDIT_LINE_AND_NOTES_PAYABLE_1

CREDIT LINE AND NOTES PAYABLE (Outstanding Notes Payable) (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Senior Debt - Term Loan	$4,683	$6,023
Senior Debt - Real Estate Loan	1,582	1,679
Subordinated Term Loan	9,409	8,659
Promissory Note Payable	860	1,075
Total	16,534	17,436
Less: Unamortized debt discount	-390	-542
Less: Current portion of notes payable, including current portion of unamortized debt discount	-1,893	-1,925
Notes payable, net of current portion	$14,251	$14,969

CREDIT_LINE_AND_NOTES_PAYABLE_2

CREDIT LINE AND NOTES PAYABLE (Additional Information) (Detail) (USD $)	12 Months Ended		9 Months Ended	12 Months Ended		9 Months Ended		0 Months Ended
	Dec. 31, 2012	Dec. 31, 2013	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2010	Sep. 30, 2014	Sep. 30, 2014	Jul. 29, 2010
			T D Bank N [Member]	Subordinated Term Loan [Member]	Subordinated Term Loan [Member]	Term Loan [Member]	Real Estate Loan [Member]	Granite Creek Partners Agent Llc [Member]
Notes Payable [Line Items]	'	'	'	'	'	'	'	'
Debt Instrument, Periodic Payment, Principal	'	'	'	'	'	$148,000	$10,000	'
Long term debt maturities, 2015	'	'	'	'	'	2,500,000	1,400,000	'
Subordinated Borrowing, Interest Rate	'	'	'	'	'	'	'	11.00%
Debt Instrument Convertible Number Of Equity Instrument	'	'	'	'	'	'	'	2,666,667
Debt Instrument, Convertible, Conversion Price	'	'	'	'	'	'	'	$3.19
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	'	'	'	'	160,000	'	'	'
Amendment and adjustment to the fair value of warrants issued in conjunction with issuance of subordinated term loan recorded within warrant liability	94,000	'	'	207,000	'	'	'	'
Issuance Of Loan	'	'	'	'	'	'	'	8,500,000
Common Stock To Purchase Of Warrants	'	455,514	'	'	'	'	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	'	5,000,000	'	'	'	'	'
Line of Credit Facility, Interest Rate Description	'	'	'Interest is payable monthly and is determined based on (i) the Prime Rate, plus 3%.	'	'	'	'	'
Line of Credit Facility, Interest Rate During Period	'	'	6.25%	'	'	'	'	'
Line of Credit Facility, Amount Outstanding	'	'	1,800,000	'	'	'	'	'
Line Of Credit Facility Borrowing Availability	'	'	$1,100,000	'	'	'	'	'
Class of Warrant or Right, Exercise Price of Warrants or Rights	'	$0.01	'	'	$1.50	'	'	'

PREFERRED_STOCK_AND_STOCK_WARR2

PREFERRED STOCK AND STOCK WARRANTS (Schedule Of Common Warrants) (Detail) (Common Warrant [Member], USD $)	1 Months Ended	12 Months Ended
	Jul. 30, 2014	Dec. 31, 2013
	Number	Number
Common Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Stock price of underlying equity	$0.07	$0.69
Exercise price	$0.65	$0.65
Expected volatility (standard deviation)	100.00%	100.00%
Annual risk-free rate	2.49%	3.04%
Expected term (time to expiration years)	'9 years 3 months 18 days	'9 years 10 months 24 days
Number of periods	485	514
Period interval	0.019	0.019
Period risk-free rate	0.05%	0.06%
Number of simulations	500,000	500,000

PREFERRED_STOCK_AND_STOCK_WARR3

PREFERRED STOCK AND STOCK WARRANTS (Schedule Of Preferred Warrants) (Detail) (USD $)	1 Months Ended	12 Months Ended
	Jul. 30, 2014	Dec. 31, 2013
Class of Warrant or Right [Line Items]	'	'
Exercise price	'	$0.01
Preferred Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Stock price of underlying equity	$12.63	$32.50
Exercise price	$0.05	$0.05
Expected term (years)	'1 year 2 months 1 day	'1 year 8 months 12 days
Risk-free interest rate	0.20%	0.13%
Volatility	70.00%	70.00%

PREFERRED_STOCK_AND_STOCK_WARR4

PREFERRED STOCK AND STOCK WARRANTS (Schedule Of Change In The Fair Value Of The Warrants Liability) (Detail) (USD $)	1 Months Ended	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Jul. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Class of Warrant or Right [Line Items]	'	'	'	'	'
Warrant liability at December 31, 2013	'	'	'	$6,373	'
Warrants amended in connection with refinancing	'	'	'	72	'
Warrant exercise	'	'	'	-44	'
Change in fair value of warrants	1,500	197	0	-4,844	0
Termination of Common and Preferred Warrants	'	'	'	-1,524	'
Warrant liability at September 30, 2014	'	33	'	33	'
Common Warrant [Member]	'	'	'	'	'
Class of Warrant or Right [Line Items]	'	'	'	'	'
Warrant liability at December 31, 2013	'	'	'	4,081	'
Warrants amended in connection with refinancing	'	'	'	0	'
Warrant exercise	'	'	'	0	'
Change in fair value of warrants	'	'	'	-3,331	'
Termination of Common and Preferred Warrants	'	'	'	-750	'
Warrant liability at September 30, 2014	'	0	'	0	'
Preferred Warrant [Member]	'	'	'	'	'
Class of Warrant or Right [Line Items]	'	'	'	'	'
Warrant liability at December 31, 2013	'	'	'	1,997	'
Warrants amended in connection with refinancing	'	'	'	0	'
Warrant exercise	'	'	'	0	'
Change in fair value of warrants	'	'	'	-1,223	'
Termination of Common and Preferred Warrants	'	'	'	-774	'
Warrant liability at September 30, 2014	'	0	'	0	'
JFC Warrant [Member]	'	'	'	'	'
Class of Warrant or Right [Line Items]	'	'	'	'	'
Warrant liability at December 31, 2013	'	'	'	54	'
Warrants amended in connection with refinancing	'	'	'	0	'
Warrant exercise	'	'	'	-44	'
Change in fair value of warrants	'	'	'	-10	'
Termination of Common and Preferred Warrants	'	'	'	0	'
Warrant liability at September 30, 2014	'	0	'	0	'
Subordinated Term Loan Warrants [Member]	'	'	'	'	'
Class of Warrant or Right [Line Items]	'	'	'	'	'
Warrant liability at December 31, 2013	'	'	'	241	'
Warrants amended in connection with refinancing	'	'	'	72	'
Warrant exercise	'	'	'	0	'
Change in fair value of warrants	'	'	'	-280	'
Termination of Common and Preferred Warrants	'	'	'	0	'
Warrant liability at September 30, 2014	'	$33	'	$33	'

PREFERRED_STOCK_AND_STOCK_WARR5

PREFERRED STOCK AND STOCK WARRANTS (Additional Information) (Detail) (USD $)

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

1 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

1 Months Ended

1 Months Ended

Jul. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Jul. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Jul. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Jul. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Jul. 30, 2014

Jul. 30, 2014

Jul. 30, 2014

Jul. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Jul. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Nov. 19, 2013

Sep. 30, 2014

Jul. 30, 2014

Dec. 31, 2013

Nov. 19, 2013

Jul. 30, 2014

Nov. 19, 2013

Nov. 19, 2013

Jul. 30, 2014

Series A Preferred Stock [Member]

Series A Convertible Preferred Stock [Member]

Series A Convertible Preferred Stock [Member]

Convertible Preferred Stock [Member]

Convertible Preferred Stock [Member]

Convertible Preferred Stock [Member]

Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Series C Convertible Preferred Stock [Member]

Series B and Series C Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series B Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Series C Preferred Stock [Member]

Common Warrant [Member]

Common Warrant [Member]

Preferred Warrant [Member]

Preferred Warrant [Member]

Preferred Warrant [Member]

Preferred Warrant [Member]

Purchase Agreement [Member]

Purchase Agreement [Member]

Purchase Agreement [Member]

Purchase Agreement [Member]

Maximum [Member]

Minimum [Member]

Series A Preferred Stock [Member]

Series A Preferred Stock [Member]

Convertible Preferred Stock [Member]

Series B Convertible Preferred Stock [Member]

Preferred Stock Disclosure [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Shares Authorized

'

'

'

'

'

'

'

1,000,000

1,000,000

'

'

'

'

'

1,000,000

1,000,000

'

1,000,000

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Other

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

1,000

123,077

'

'

Stock Issued During Period, Value, Other

'

'

'

$241,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0

'

'

'

'

'

'

'

'

'

'

'

'

$2,000,000

$4,000,000

'

'

Sale of Stock, Price Per Share

'

'

'

'

'

$0.69

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$2,000

$32.50

'

'

Preferred Stock Par Or Stated Value Per Share

'

'

'

'

'

'

'

$0.00

$0.00

'

'

'

'

$0.00

$0.00

$0.00

$0.00

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.00

'

Preferred Stock, Liquidation Preference Per Share

'

$32.50

'

$32.50

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3,000

$2,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock, Shares Issued upon Conversion

'

50

'

50

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock Conversion price

$0.14

'

'

$0.65

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock, Dividend Rate, Percentage

'

'

'

12.00%

'

'

'

'

'

'

'

'

'

'

'

'

12.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Class Of Warrant Or Right, Number Of Securities Called By Warrants Or Rights

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6,153,830

'

'

'

123,077

'

'

'

'

Exercise price

'

'

'

'

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.65

'

$0.05

$0.05

$0.05

'

'

'

'

Proceeds from Issuance of Preferred Stock and Preference Stock

1,300,000

'

'

2,000,000

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

1,400,000

'

'

'

'

600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of Stock, Shares Converted

'

'

'

'

'

'

'

'

'

'

'

'

'

35,713.15

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000

Percentage Of Common Stock Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40.00%

'

'

'

Preferred Stock, Conversion Basis

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'if the Company issues or sells shares of Common Stock or other equity securities for no consideration or for consideration that is based on an equity valuation of the Company of less than $2 million in the aggregate (a “Trigger Issuance”). Pursuant to Section 8.5 (a), in the event of a Trigger Issuance, the Conversion Number shall be increased as of the close of business on the effective date of the Trigger Issuance to a number calculated as follows: (i) two-thirds of the Common Stock deemed Outstanding immediately following such Trigger Issuance (excluding any Common Stock Deemed Outstanding as a result of the conversion of the Series B Preferred Stock) (ii) divided by 1,000. Each share of Series B Preferred Stock will automatically convert into shares of Common Stock on the tenth anniversary of its original issuance date, at the then-current Conversion Number.

Preferred Stock Liquidation Preference Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Liquidation Value as per the Certificate of Designation is: the greater of (1) 150% of the Purchase Price ($3,000 per share) or (2) the Base Value ($2,000 per share plus accrued and unpaid dividends).

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock Dividend Payable Percentage Of Shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

75.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Dividends, Preferred Stock, Paid-in-kind

'

'

'

'

'

'

'

'

'

'

'

375,000

0

'

'

'

2,000

'

'

'

'

'

'

'

'

'

'

'

'

'

41,000

0

'

'

'

'

'

'

'

'

'

'

Fair Value Adjustment of Warrants

1,500,000

197,000

0

-4,844,000

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-3,331,000

'

-1,223,000

'

'

'

'

'

'

'

Preferred Stock Fair Value Estimated

'

'

'

'

'

'

1,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock Dividends, Income Statement Impact

'

'

'

'

'

'

2,400,000

'

'

130,000

0

375,000

0

'

'

'

'

'

'

'

'

'

'

1,098,000

0

1,098,000

0

1,400,000

41,000

0

41,000

0

'

'

'

'

'

'

'

'

'

'

Convertible To Common Stock Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred Stock Beneficial Conversion Feature

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$1,100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

INCOME_TAXES_Additional_Inform

INCOME TAXES (Additional Information) (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Effective Income Tax Rate Reconciliation, Percent, Total	1.00%	20.00%	4.00%	24.00%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	34.00%	'	34.00%	'
Current Foreign Tax Expense (Benefit)	$112,000	'	$269,000	'
Deferred Tax Assets, Valuation Allowance, Noncurrent	$9,000,000	'	$9,000,000	'

RELATED_PARTY_TRANSACTIONS_Add

RELATED PARTY TRANSACTIONS (Additional Information) (Detail) (USD $)

1 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

1 Months Ended

9 Months Ended

Jul. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Jan. 31, 2014

Nov. 19, 2013

Sep. 30, 2014

Dec. 31, 2012

Dec. 31, 2012

Apr. 30, 2014

Sep. 30, 2014

Jfc [Member]

Jfc [Member]

Jfc [Member]

Seller Of Csp [Member]

Amended JFC Note [Member]

Amended JFC Note [Member]

Selway [Member]

Selway [Member]

First Conversion [Member]

Related Party Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unsecured Debt

'

'

'

'

'

'

$2,100,000

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

'

'

'

'

'

12.00%

'

'

'

Line of Credit Facility, Amount Outstanding

'

'

'

'

'

'

5,000,000

'

'

'

'

'

'

'

Convertible Debt

'

'

'

'

'

'

'

'

'

'

1,000,000

'

'

'

Debt Instrument, Convertible, Conversion Price

'

'

'

'

'

'

'

'

'

'

$32.50

'

'

'

Debt Conversion, Description

'

'

'

'

'

'

'

'

'

'

'

'upon conversion of the first $499,980 of Amended JFC Note principal, JFC originally would have been entitled to receive: (1) warrants to purchase, for each $6.50 of principal amount converted, ten shares of the Company’s common stock, and (2) warrants to purchase for each $32.50 of principal amount converted, one share of Series A Preferred Stock.

'

'

Class of Warrant or Right, Number of Securities Called by Each Warrant or Right

'

'

'

'

'

'

'

'

73,009

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

1,000

'

'

'

'

'

350,000

'

'

'

'

'

242,308

'

Sale of Stock, Price Per Share

'

'

'

'

'

$0.69

'

'

'

'

'

'

'

'

Other Liabilities, Current

'

0

'

0

'

242,000

'

'

'

'

'

'

'

'

Class Of Warrant Or Right, Outstanding

'

'

'

'

'

'

'

350,000

'

'

'

'

'

'

Common Stock Closing Price

'

'

'

'less than $1.75.

'

'

'

'

'

'

'

'

'

'

Monthly Lease Payments Due To Related Parties

'

'

'

'

'

'

'

'

'

30,000

'

'

'

'

Due To Related Party For Services

'

'

'

'

'

'

'

'

'

'

'

'

158,000

11,000

Consulting Agreement Fees Payable Monthly

'

1,000

'

1,000

'

'

'

'

'

'

'

'

'

'

Consulting Agreement Fees Payable Monthly Amended Effective From June 2014

'

10,000

'

10,000

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights

'

'

'

'

'

$0.01

'

'

$0.01

'

'

'

'

'

Gains (Losses) on Extinguishment of Debt

$500,000

($527,000)

$0

($527,000)

$0

'

'

'

'

'

'

'

'

'

NET_INCOME_LOSS_PER_COMMON_SHA

NET INCOME (LOSS) PER COMMON SHARE (Net Income (Loss) Per Common Share) (Detail) (USD $)	1 Months Ended	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jul. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Numerator (in thousands):	'	'	'	'	'
Net loss	'	($10,273)	($7,804)	($7,675)	($9,662)
Net Loss Available To Common Stockholders - Basic And Diluted	'	'	'	'	'
Loss available to common stockholders - basic and diluted	'	-15,365	-7,804	-13,012	-9,662
Loss per common share:	'	'	'	'	'
Basic and diluted	'	($0.72)	($0.38)	($0.61)	($0.47)
Series A Convertible Preferred Stock [Member]	'	'	'	'	'
Net Loss Available To Common Stockholders - Basic And Diluted	'	'	'	'	'
Preferred Stock Dividends, Income Statement Impact	'	-130	0	-375	0
Series C Preferred Stock [Member]	'	'	'	'	'
Net Loss Available To Common Stockholders - Basic And Diluted	'	'	'	'	'
Preferred Stock Dividends, Income Statement Impact	-1,400	-41	0	-41	0
Series A deemed dividend [Member]	'	'	'	'	'
Net Loss Available To Common Stockholders - Basic And Diluted	'	'	'	'	'
Preferred Stock Dividends, Income Statement Impact	'	-2,422	0	-2,422	0
Series B deemed dividend [Member]	'	'	'	'	'
Numerator (in thousands):	'	'	'	'	'
Net loss	'	'	'	0	'
Net Loss Available To Common Stockholders - Basic And Diluted	'	'	'	'	'
Preferred Stock Dividends, Income Statement Impact	'	-1,098	0	-1,098	0
Series C deemed dividend [Member]	'	'	'	'	'
Net Loss Available To Common Stockholders - Basic And Diluted	'	'	'	'	'
Preferred Stock Dividends, Income Statement Impact	'	($1,401)	$0	($1,401)	$0

NET_INCOME_LOSS_PER_COMMON_SHA1

NET INCOME (LOSS) PER COMMON SHARE (Dilutive Common Share Equivalents Were Excluded From The Calculation Of Diluted Net Income Per Common Share) (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Options [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Shares excluded from the calculation of diluted net income per common share	2,636,186	3,226,186	2,636,186	3,226,186
Restricted Stock [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Shares excluded from the calculation of diluted net income per common share	0	23,024	0	22,704
Warrants [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Shares excluded from the calculation of diluted net income per common share	455,514	0	455,514	0
Convertible Debt Securities [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Shares excluded from the calculation of diluted net income per common share	2,666,667	2,666,667	2,666,667	2,666,667

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Additional Information) (Detail) (USD $)

3 Months Ended

9 Months Ended

9 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Nov. 20, 2013

Dec. 31, 2013

Nov. 19, 2013

Nov. 19, 2013

Jul. 18, 2011

Jul. 18, 2011

Promissory Note [Member]

Mr.Colon [Member]

Mr.Colon [Member]

Mr.Colon [Member]

Mr.Colon [Member]

Omniglow [Member]

Omniglow [Member]

Promissory Note [Member]

Five Year Annal Installments [Member]

Attorney Fees and Costs [Member]

Commitments and Contingencies Disclosure [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Loss Contingency, Damages Awarded, Value

'

'

'

'

'

'

'

'

'

'

$2,600,000

$235,000

Prejudgment Interest Rate

'

'

'

'

'

'

'

'

'

'

12.00%

12.00%

Loss contingency damages awarded accrued interest

'

'

'

'

'

'

'

'

'

'

1,300,000

'

Escrow Shares Fair Value

'

'

'

'

625,139

'

'

'

'

'

'

'

Contingent legal obligation

2,700,000

'

2,700,000

'

'

'

'

'

'

'

'

'

Litigation Settlement, Amount

'

'

'

'

'

'

'

'

1,075,000

215,000

'

'

Payments for Legal Settlements

'

'

0

-2,038,000

'

'

275,000

'

'

'

'

'

Legal settlement

0

2,038,000

0

2,038,000

'

'

'

2,000,000

'

'

'

'

Repayments of Debt

'

'

'

'

'

$215,000

'

'

'

'

'

'

Loss Contingency, Settlement Agreement, Terms

'

'

'Pursuant to the Omniglow Settlement Agreement, CTI agreed to either pay the full settlement amount of approximately $4.5 million or satisfy the settlement amount as follows: (i) an initial payment of $250,000, (ii) transfer the 625,139 Escrowed Shares, (iii) payment of $1.0 million in cash within 21 days from the execution of the Omniglow Settlement Agreement (see Note 14) and (iv) additional payments in cash and/or through cooperative marketing credits of $1.9 million if paid within 18 months from the date of the Omniglow Settlement Agreement, or of approximately $2.4 million if paid within 27 months from the date of the Omniglow Settlement Agreement

'

'

'

'

'

'

'

'

'

FAIR_VALUES_OF_ASSETS_AND_LIAB2

FAIR VALUES OF ASSETS AND LIABILITIES (Assets And Liabilities Measured At Fair Value On Recurring Basis) (Detail) (USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'
Fair Value Assets And Liabilities Measured On Recurring Basis	($33)
Warrants [Member]	'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'
Fair Value Assets And Liabilities Measured On Recurring Basis	-33	[1]
Level 1 Quoted Prices in Active Markets for Identical Assets [Member]	'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'
Fair Value Assets And Liabilities Measured On Recurring Basis	0
Level 1 Quoted Prices in Active Markets for Identical Assets [Member] | Warrants [Member]	'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[1]
Level 2 Significant Other Observable Inputs [Member]	'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'
Fair Value Assets And Liabilities Measured On Recurring Basis	0
Level 2 Significant Other Observable Inputs [Member] | Warrants [Member]	'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[1]
Level 3 Significant Unobservable Inputs [Member]	'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'
Fair Value Assets And Liabilities Measured On Recurring Basis	-33
Level 3 Significant Unobservable Inputs [Member] | Warrants [Member]	'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'
Fair Value Assets And Liabilities Measured On Recurring Basis	($33)	[1]
[1]	The Company has classified its warrants liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model.

FAIR_VALUES_OF_ASSETS_AND_LIAB3

FAIR VALUES OF ASSETS AND LIABILITIES (Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis) (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Trademarks and Trade Names [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair Value Measurement Reporting Unit	'Training	[1],[2]
Loss Recognized	$4,223	[2]
Fair Value	790	[2]
Patents [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair Value Measurement Reporting Unit	'Training	[1],[3]
Loss Recognized	4,877	[3]
Fair Value	$2,700	[3]
[1]	The Company is managed as one operating segment with three reporting units: Chemical Light (the operations of CTI and CTSAS), Specialty Products (the operations of CSP) and Other (the operations of CRI and the parent company Cyalume Technologies Holdings, Inc.). Both Chemical Lightsb goodwill and Specialty Productsb goodwill was not considered to be impaired and our Other reporting unit does not have a goodwill asset.
[2]	The fair value of the impaired trademarks and trade names asset was determined using the brelief from royaltyb method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the trademarks and trade names, net of estimated income taxes (an income approach).
[3]	The fair value of the impaired patent asset was determined using the brelief from royaltyb method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the patents, net of estimated income taxes (an income approach).

SUPPLEMENTAL_DISCLOSURE_OF_CAS2

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Cash Paid for Interest and Income Taxes) (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Interest	$456	$1,250
Income taxes	$171	$120

SUPPLEMENTAL_DISCLOSURE_OF_CAS3

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Non-Cash Investing and Financing Activities) (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Non-Cash Investing And Financing Activities [Line Items]	'	'
Litigation award payable accounted for as a receivable due from related party	$0	$134
Adjustment to warrant liability upon warrant exercise	44	0
Issuance of 350,000 shares to JFC in connection with settling a contingent consideration liability resulting from the acquisition of CSP	241	0
Issuance of 242,308 shares to Selway	157	0
Series A Convertible Preferred Stock [Member]	'	'
Non-Cash Investing And Financing Activities [Line Items]	'	'
Preferred stock accrued dividend	375	0
Series C Preferred Stock [Member]	'	'
Non-Cash Investing And Financing Activities [Line Items]	'	'
Preferred stock accrued dividend	$41	$0

SUPPLEMENTAL_DISCLOSURE_OF_CAS4

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION (Non-Cash Investing and Financing Activities) (Parenthetical) (Detail)	9 Months Ended
	Sep. 30, 2014
Cyalume Specialty Products [Member]	'
Non-Cash Investing And Financing Activities [Line Items]	'
Stock Issued During Period Shares Contingent Consideration Liability	350,000
Selway [Member]	'
Non-Cash Investing And Financing Activities [Line Items]	'
Stock Issued During Period Value Related Party	242,308